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Objective
Since many patients with juvenile idiopathic arthritis
(JIA) are lost to follow-up in adulthood, we have started a
transition clinic with further follow-up, in order to assess
the outcome of adults who had JIA during childhood and
who still have active inflammatory arthritis.
Methods
18 patients (13 female, 5 male) seen since the year 1998
and regularly followed at the rheumatology clinic are
included.
Results
The mean age is 29 years; the mean duration of disease is
22 years. 8 were polyarticular in onset (all rheumatoid fac-
tor negative): joint erosions are noted in 4, hip replace-
ment in 2, amyloidosis in 1 (renal graft); 5 are on
methotrexate, 3 on etanercept; functional impairment is
evident in 1/8, seven are employed.
Of the 10 who had systemic-onset disease, erosions are
present in 4, hip replacement in 2, amyloidosis in 1; 3 are
treated with methotrexate, 1 leflunomide, 3 etanercept;
disability in 3, 4 are students and 3 are employees.
Globally 33% of patients need anti TNF, while 83% work.
Conclusion
Studies of the outcome of JIA at adult age with persistent
inflammatory symptoms are few. This cohort emphasizes
the need of prolonged treatment with methotrexate and
anti TNF in cases of active disease. However, overall prog-
nosis looks relatively good in term of work ability.
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